VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AIP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AIPArteris, Inc.
$47.36$2.2B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAIPFinancials

Arteris, Inc. (AIP) Financials

7Y historyFree accessUpdated daily

Revenue growth accelerated to 38.7% in 2026Q1, yet the firm continues to struggle with profitability, maintaining an operating margin of negative 38.0% despite a robust 83.0% gross margin.

AIP Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19
Sales/Revenue76.98M70.58M57.72M53.67M50.38M37.86M31.81M31.5M
Revenue Growth %25.57%22.27%7.56%6.53%33.05%19.02%0.99%-
Cost of Goods Sold9.27M6.89M5.96M5.08M4.28M3.73M1.49M1.86M
COGS % of Revenue-9.77%10.33%9.46%8.5%9.85%4.69%5.91%
Gross Profit67.72M63.68M51.76M48.59M46.1M34.13M30.32M29.64M
Gross Margin %87.96%90.23%89.67%90.54%91.5%90.15%95.31%94.09%
Gross Profit Growth %-23.03%6.53%5.41%35.05%12.57%2.3%-
Operating Expenses101.86M96.82M83.36M83.73M74.95M55.9M34.1M22.37M
OpEx % of Revenue-137.18%144.41%156.02%148.78%147.63%107.19%71%
Selling, General & Admin50.01M46.91M38.35M38.6M33.79M25.09M17.08M12.31M
SG&A % of Revenue-66.47%66.44%71.93%67.06%66.25%53.68%39.09%
Research & Development52.5M49.91M45.01M45.13M41.17M30.81M17.02M10.05M
R&D % of Revenue-70.71%77.97%84.09%81.72%81.38%53.5%31.91%
Other Operating Expenses-646K0000000
Operating Income-34.15M-33.14M-31.6M-35.14M-28.86M-21.77M-3.78M7.27M
Operating Margin %-44.35%-46.95%-54.74%-65.48%-57.28%-57.48%-11.87%23.09%
Operating Income Growth %--4.88%10.09%-21.78%-32.58%-476.25%-151.93%-
EBITDA-30.27M-29.76M-28.23M-32.07M-26.76M-20.27M-2.84M8.03M
EBITDA Margin %-39.32%-42.17%-48.91%-59.76%-53.11%-53.54%-8.93%25.49%
EBITDA Growth %-12.95%-5.41%11.97%-19.87%-31.98%-613.59%-135.38%-
D&A (Non-Cash Add-back)3.88M3.38M3.36M3.07M2.1M1.49M936K756K
EBIT-33.21M-33.14M-28.2M-31.58M-27.43M-21.77M-2.18M7.27M
Net Interest Income-183K-193K-244K-211K1.34M-579K-50K-290K
Interest Income00001.43M000
Interest Expense183K193K244K211K89K579K50K290K
Other Income/Expense-2.93M-134K458K-50K1.05M-579K1.54M-290K
Pretax Income-37.08M-33.27M-31.14M-35.19M-27.8M-22.34M-2.23M6.98M
Pretax Margin %-48.16%-47.14%-53.94%-65.58%-55.19%-59.01%-7.02%22.17%
Income Tax-2.49M1.48M2.5M1.68M-417K1.04M1.03M1.14M
Effective Tax Rate %6.72%-4.43%-8.03%-4.77%1.5%-4.65%-45.93%16.38%
Net Income-34.58M-34.75M-33.64M-36.87M-27.39M-23.38M-3.26M5.84M
Net Margin %-44.92%-49.23%-58.27%-68.7%-54.36%-61.76%-10.25%18.54%
Net Income Growth %-6.89%-3.29%8.76%-34.62%-17.12%-617.3%-155.83%-
Net Income (Continuing)-34.58M-34.75M-33.64M-36.87M-27.39M-23.38M-3.26M5.84M
Discontinued Operations00000000
Minority Interest00000000
EPS (Diluted)-0.76-0.82-0.86-1.03-0.84-1.06-0.100.21
EPS Growth %3.66%4.65%16.5%-22.62%20.75%-960%-147.62%-
EPS (Basic)--0.82-0.86-1.03-0.84-1.06-0.100.21
Diluted Shares Outstanding45.54M42.29M38.91M35.68M32.58M21.97M31.53M22.05M
Basic Shares Outstanding45.54M42.29M38.91M35.68M32.58M21.97M31.53M22.05M
Dividend Payout Ratio--------

Key Metrics

Growth RegimeAccelerating
ProfitabilityNegative
Balance SheetStrained
Cash FlowBurning
Top Statement Risk

Persistent Operating Cash Burn

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Revenue Growth Momentum Accelerating Rapidly

As reported in recent financial filings, Arteris achieved a 38.7% year-over-year revenue growth in 2026Q1, marking a significant acceleration from the low-double-digit growth observed in previous quarters, suggesting that the company's strategic focus on high-complexity AI and automotive SoC design starts is beginning to yield tangible results.

The recent revenue surge indicates that the company's interconnect IP is gaining traction in high-growth compute segments where architectural complexity necessitates specialized data pathways. Investors should monitor whether this growth is driven by a broader customer base or if it remains concentrated in a few large-scale design wins that could introduce future volatility.

Structural Gross Margin Excellence Persists

According to the provided income statement data, Arteris maintains a robust gross margin profile, consistently hovering near 90%, which reflects the inherent scalability of its intellectual property licensing model and the minimal incremental cost associated with delivering its software-defined interconnect solutions to new semiconductor design projects.

This high-margin structure is a hallmark of pure-play IP providers, yet it remains disconnected from the company's bottom-line performance due to heavy R&D investment. While the gross margin is impressive, it highlights that the primary challenge is not product profitability but rather the massive operating expense burden required to maintain competitive technical relevance.

Operating Leverage Remains Elusive Currently

Based on the quarterly income statement figures, Arteris continues to struggle with operating leverage, as operating expenses—specifically R&D and SG&A—have largely tracked with revenue growth, resulting in persistent operating losses that have not yet shown a clear path to a sustainable break-even point for the firm.

The company's inability to scale operating income faster than gross profit suggests that the business remains in a heavy investment phase, prioritizing market share and engineering headcount over immediate profitability. Analysts should watch for a potential divergence where revenue growth begins to outpace the growth of operating expenses, which would signal a transition toward operational maturity.

Stock-Based Compensation Masks True Burn

Analysis of the reported financials reveals that stock-based compensation, which reached $5.5 million in 2026Q1, represents a significant portion of the operating loss, suggesting that the company's GAAP net income figures may understate the actual cash burn required to retain the specialized engineering talent necessary for its operations.

The reliance on equity-based incentives is common in high-growth technology firms, but it creates a persistent dilution risk for shareholders that must be weighed against the company's long-term growth prospects. Investors should adjust for these non-cash expenses to better understand the underlying cash runway and the true cost of maintaining the current R&D trajectory.

Sustainability of High-Growth Narrative Challenged

While the recent revenue acceleration is notable, the company's reliance on lumpy licensing deals and the potential for increased competition from hyperscalers developing internal interconnect technologies warrant caution, as these factors could lead to significant margin compression if the royalty-based revenue stream fails to materialize as expected.

Short-term growth may be masking structural risks, particularly the company's vulnerability to geopolitical export controls and the potential for a slowdown in semiconductor R&D spending. If the anticipated royalty tail from current design wins does not scale, the company may face a difficult choice between further dilutive financing or a reduction in the R&D spending that currently fuels its competitive moat.

AIP — Frequently Asked Questions

Quick answers to the most common questions about buying AIP stock.

What was Arteris, Inc.'s (AIP) revenue in 2025?

For fiscal year 2025, Arteris, Inc. (AIP) reported total revenue of $70.6M. This represents a 124.1% increase compared to $31.5M in 2019.

Is Arteris, Inc. (AIP) profitable?

Arteris, Inc. (AIP) reported a net loss of $34.7M for the fiscal year ending 2025.

What is Arteris, Inc.'s operating profit margin?

Arteris, Inc. (AIP) reported an operating income of $-33.1M, resulting in an operating profit margin of -47.0%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Arteris, Inc.'s gross profit and gross margin?

Arteris, Inc. (AIP) generated $63.7M in gross profit for the year, representing a gross profit margin of 90.2%. This demonstrates the company's core pricing power and production efficiency.